Source: Oleksandr.
  • Canopy Growth has signed subscription agreements with numerous institutions for a combined US$30 million investment
  • The funds, priced at US$4.29 per unit, will go towards general corporate purposes, paying down debt and strengthening the company’s working capital position
  • Canopy Growth is a North American cannabis and consumer packaged goods company with a brand portfolio including Doja, 7ACRES, Tweed, Deep Space, Martha Stewart CBD and Storz & Bickel
  • Canopy Growth stock opened with a loss of 9.05 per cent, trading at C$6.13 per share as of 9:40 am ET

Canopy Growth (TSX:WEED; NDAQ:CGC) has signed subscription agreements with numerous institutions for a combined US$30 million investment.

The company will sell 6,993,007 units priced at US$4.29 under a private placement and allocate the funds to general corporate purposes, paying down debt and bolstering its working capital position.

Each unit is composed of one Canopy Growth common share and one common share purchase warrant (either Series A or B). Each warrant allows the holder to purchase one common share for US$4.83. Series A warrants are immediately exercisable for five years after the closing of the offering, while Series B warrants are exercisable for five years only six months after the closing of the offering.

The company expects the private placement to close on Wednesday.

Investors interested in further due diligence should consult our extensive coverage of the cannabis stock, including:

Canopy Growth is a North American cannabis and consumer packaged goods company. Its brands include Doja, 7ACRES, Tweed, Deep Space, Martha Stewart CBD and Storz & Bickel.

The company has positioned itself to capitalize on U.S. cannabis legalization through its rights to Acreage Holdings, a vertically integrated multi-state cannabis operator, Wana Brands, a cannabis edibles brand, and Jetty Extracts, a producer of cannabis extracts and a pioneer of clean vape technology.

Canopy Growth stock (TSX:WEED) opened with a loss of 9.05 per cent, trading at C$6.13 per share as of 9:40 am ET. The stock has fallen by more than 80 per cent year-over-year and by more than 95 per cent since 2019.

Join the discussion: Find out what everybody’s saying about this cannabis stock on the Canopy Growth Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online

Cannabix’s Marijuana Breath Test hits the market

Cannabix (CSE:BLO) begins the commercial rollout for its Marijuana Breath Test, including deliveries to customers across numerous industries.
Stock Talk Cannabis Report image of cannabis plants and VW van

StockTalk | Cannabis Report: Relaunching business into the spring

Ascend Wellness Holdings, Inc. (CSE: AAWH.U / OTCQX:AAWH), a multi-state, vertically integrated cannabis operator, has relaunched...

Quit smoking with psychedelics? A new frontier for treatment — and investors

A new Johns Hopkins study found that a single dose of psilocybin, combined with therapy, helped smokers stay cigarette free at six months.
Cannabis Report image of farmed cannabis plants

StockTalk | Cannabis Report: Rolling in profits

Nextleaf Solutions turned a profit in fiscal Q1 2026, which ended on December 31, 2025, reflecting momentum...